LTRN Soared
Fri, Sep 11, 2020 at 05:30 PM
LTRN (LTRN:NASDAQ) rocketted at $19.24, representing a gain of 27.8%. The stock appeared on our News Catalysts scanner on Fri 11 Sep 20 at 12:11 PM in the 'INSIDER' category. From Thu 27 Aug 20, the stock recorded 33.33% Up Days and 40.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About LTRN (LTRN:NASDAQ)
Lantern Pharma Inc is a clinical-stage biotechnology company. It is focused on leveraging artificial intelligence machine learning and genomic data to streamline the drug development process and to identify the patients that will benefit from targeted oncology therapies. The firm's pipeline of development programs involves three small molecule drug candidates namely LP-100, LP-184, and LP-300.
Top 10 Gainers:
- Hancock Jaffe Laboratories, Inc. (HJLI:NASDAQ), 37.51%
- Salem Media Group, Inc. (SALM:NASDAQ), 35.57%
- NNOX (NNOX:NASDAQ), 32.87%
- LTRN (LTRN:NASDAQ), 27.84%
- A-Mark Precious Metals, Inc. (AMRK:NASDAQ), 27.21%
- Cinedigm Corp. (CIDM:NASDAQ), 27.09%
- Cleveland BioLabs, Inc. (CBLI:NASDAQ), 22.75%
- Natural Health Trends Corp. (NHTC:NASDAQ), 21.6%
- Biofrontera AG (BFRA:NASDAQ), 18.97%
- Teligent, Inc. (TLGT:NASDAQ), 18.8%